BETHESDA, MD–StonebridgeCarras and The Donohoe Cos. are moving forward with plans to begin construction in the third quarter of 2019 for their project at 8280 Wisconsin Ave. They also unveiled their plans for the 175,000-square foot building, which is expected to deliver in the summer of 2012: namely to create a commercial center for life sciences.
The companies are working for approvals with Maryland National Capital Park and Planning Commission with the hope of securing them by this Fall.
StonebridgeCarras and Donohoe describe their vision for the project, Bethesda Bio, as the meeting of two trends: 1) companies locating their operations near mass transportation and in vibrant urban areas and 2) life sciences companies seeking to be close to institutions driving research and advancement.
Recommended For You
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Erika Morphy
Erika Morphy has been writing about commercial real estate at GlobeSt.com for more than ten years, covering the capital markets, the Mid-Atlantic region and national topics. She's a nerd so favorite examples of the former include accounting standards, Basel III and what Congress is brewing.
